Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months.

Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and ...

At WHX 2026 Dubai, Andrew Craig, author of Our Future Is Biotech, outlines why he believes this century will be defined not by physics and technology, but by ...

Steve Pagliuca, Senior Advisor at Bain Capital, says AI is disrupting software valuations while accelerating biotech ...

This was a very rapid 48-hour massacre,” the head of an advocacy group tracking the victims of government violence said.

Datavault AI signed $49M of Tokenization and Technology Licensing agreements in Q4'25 that impact FY2025 and FY2026 ...

Jay Woods of Freedom Capital Markets explains why tech is digesting gains after years of outperformance.

The unsupported spiral staircase, called the Ribbon of Pearl River, is located in the OneM Center for Contemporary Art in Guangzhou. Government shutdown: Republicans consider escape hatch as Congress ...

Publishing firm COL Group Co. surged to its 20% daily upper trading limit, while Shanghai Film Co. and gaming and ...

The red wolf ( Canis rufus) is a medium-sized canid that stands about 26 inches (66 centimeters) at the shoulder and measures ...

We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize ...